Rhino 70000: Affected lots may contain the undeclared ingredient sildenafil
Last updated
Summary
Product
Rhino 70000
Issue
Health products
What to do
Consult your health care professional if you have any health concerns.
Distribution
Quebec
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
---|---|---|---|---|---|
Rhino 70000 |
Rhino 70000 |
Not licensed |
Capsule |
N/A |
All lots |
Issue
Affected lots may contain the undeclared ingredient sildenafil.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
7067941 Canada Inc. (D.N.B.)
1264 rue Brodeur, Saint-Paul-d'Abbotsford
Québec, J0E1A0
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
Quebec
Recall class
Type I
Identification number
RA-74097
Get notified
Receive notifications for new and updated recalls and alerts by category.